EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cells

Jamie N Mills iD, Valerie Gunchick iD, Jake McGue, Zhaoping Qin iD, Chandan Kumar-Sinha iD, Filip Bednar iD, Noah Brown, Jiaqi Shi iD, Aaron M Udager iD, Timothy Frankel iD, Mark M Zalupski iD, Vaibhav Sahai iD

JNCI Cancer Spectrum · 2025

DOI: 10.1093/jncics/pkae097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Jamie N Mills und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Osteoclasts, Giant Cells, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Undifferentiated carcinoma (UC) is a rare subtype of pancreatic cancer distinguished from UC with osteoclast-like giant cells (UC-OGC) in 2019, affecting interpretation of literature that does not distinguish these subtypes. We sought to identify translationally relevant differences between these 2 variants and compared with pancreatic ductal adenocarcinoma.

Methods

We characterized clinical and multiomic differences between UC (n = 32) and UC-OGC (n = 15) using DNA sequencing, RNA sequencing, and multiplex immunofluorescence and compared these findings with pancreatic ductal adenocarcinoma.

Results

Characteristics at diagnosis were similar between UC and UC-OGC, though the latter was more resectable (P = .009). Across all stages, median overall survival was shorter for UC than for UC-OGC (0.4 years vs 10.8 years, respectively; P = .003). This shorter survival was retained after stratification by resection, albeit without statistical significance (1.8 years vs 11.9 years, respectively; P = .08). In a subset of patients with available tissue, the genomic landscape was similar among UC (n = 9), UC-OGC (n = 5), and pancreatic ductal adenocarcinoma (n = 159). Bulk RNA sequencing was deconvoluted and, along with multiplex immunofluorescence in UC (n = 13), UC-OGC (n = 5), and pancreatic ductal adenocarcinoma (n = 16), demonstrated statistically significantly increased antigen-presenting cells, including M2 macrophages and natural killer cells, and decreased cytotoxic and regulatory T cells in UC and UC-OGC vs pancreatic ductal adenocarcinoma. Findings were similar between UC and UC-OGC , except for decreased regulatory T cells in UC-OGC (P = .04).

Conclusions

In this series, UC was more aggressive than UC-OGC, with these variants having more antigen-presenting cells and fewer regulatory T cells than pancreatic ductal adenocarcinoma, suggesting potential for immune-modulating therapies in the treatment of these pancreatic cancer subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsOsteoclastsGiant CellsCarcinoma, Pancreatic DuctalHumansMaleFemaleAgedMiddle AgedCarcinomaSequence Analysis, RNASequence Analysis, DNAAged, 80 and over

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Current affiliation:Department of Medicine, Division of Epidemiology, Vanderbilt University, Nashville, TN, USA.
  • Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.

ORCID-Profile: Jamie N Mills, Valerie Gunchick, Zhaoping Qin, Chandan Kumar-Sinha, Filip Bednar, Jiaqi Shi, Aaron M Udager, Timothy Frankel, Mark M Zalupski, Vaibhav Sahai

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Mills, J. N., Gunchick, V., McGue, J., Qin, Z., Kumar-Sinha, C., Bednar, F., Brown, N., Shi, J., Udager, A. M., Frankel, T., Zalupski, M. M., & Sahai, V. (2025). Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cells. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae097

Vancouver

Mills JN, Gunchick V, McGue J, Qin Z, Kumar-Sinha C, Bednar F, et al. Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cells. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkae097

BibTeX
@article{Mills2025,
  author = {Mills, Jamie N and Gunchick, Valerie and McGue, Jake and Qin, Zhaoping and Kumar-Sinha, Chandan and Bednar, Filip and Brown, Noah and Shi, Jiaqi and Udager, Aaron M and Frankel, Timothy and Zalupski, Mark M and Sahai, Vaibhav},
  title = {Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cells},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  doi = {10.1093/jncics/pkae097}
}
Kostenlos starten →